Melinta Therapeutics, Inc. (MLNT) financial statements (2022 and earlier)

Company profile

Business Address 44 WHIPPANY ROAD
MORRISTOWN, NJ 07963
State of Incorp. DE
Fiscal Year End December 31
SIC 2834 - Pharmaceutical Preparations (benchmarking)
More info Complete financial analysis Financial benchmarking

Balance sheet (Statement of financial position) ($ in thousands)

12/31/2018
12/31/2017
12/31/2016
12/31/2015
12/31/2014
12/31/2013
12/31/2012
ASSETS
Current Assets
Cash, cash equivalents, and short-term investments81,808128,387231,553153,76599,11396,50370,109
Cash and cash equivalents81,808128,387231,553153,76599,11396,50370,109
Restricted cash and investments200200     
Receivables(26)7,5646,1627,6392,3501,626 
Inventory, net of allowances, customer advances and progress billings41,34110,825   
Inventory41,34110,825     
Prepaid expense 2,3335795733,388408
Prepaid expense and other current assets265
Other undisclosed current assets26,159455     
Total current assets:149,482149,764238,294161,976104,85198,53770,374
Noncurrent Assets
Property, plant and equipment1,5861,596489011313843
Intangible assets, net (including goodwill)229,1967,500   
Intangible assets, net (excluding goodwill)229,1967,500     
Deposits noncurrent assets  17373346333321
Other noncurrent assets61,3261,413    
Total noncurrent assets:292,10810,509221163459471365
TOTAL ASSETS:441,590160,273238,515162,139105,31199,00870,738
LIABILITIES AND EQUITY
Liabilities
Current Liabilities
Accounts payable and accrued liabilities55,17431,73022,85313,44614,6407,7093,118
Accounts payable16,7657,40515,6579,63511,8946,2742,172
Accrued liabilities33,92424,0412,9291,4751,002392342
Employee-related liabilities  4,2672,3371,5961,043605
Interest and dividends payable4,485284  148  
Debt  6,6674,4443,5942,2012,227
Derivative instruments and hedges, liabilities     920 
Deferred revenue and credits    32 
Other undisclosed current liabilities78,432   (148)  
Total current liabilities:133,60631,73029,52017,89118,08610,8625,345
Noncurrent Liabilities
Long-term debt and lease obligation110,47639,5558,66015,25814,87812,5387,623
Long-term debt, excluding current maturities110,47639,5558,66015,25814,87812,5387,623
Liabilities, other than long-term debt7,44416,65216,98711,32611,3265,633 
Deferred revenue and credits10,00816,98711,32611,3265,633 
Other liabilities7,4446,644     
Total noncurrent liabilities:117,92056,20725,64726,58426,20418,1717,623
Total liabilities:251,52687,93755,16744,47444,29029,03212,968
Stockholders' equity
Stockholders' equity attributable to parent, including:190,06472,336183,348117,66561,02169,97557,770
Common stock11225244373325
Additional paid in capital909,896644,973620,279436,643288,893236,202178,971
Accumulated deficit(719,843)(572,659)(436,983)(319,022)(227,910)(166,260) 
Other undisclosed stockholders' equity attributable to parent      (121,226)
Other undisclosed stockholders' equity      (178,996)
Total stockholders' equity:190,06472,336183,348117,66561,02169,975(121,226)
Other undisclosed liabilities and equity      178,996
TOTAL LIABILITIES AND EQUITY:441,590160,273238,515162,139105,31199,00870,738

Income statement (P&L) ($ in thousands)

12/31/2018
12/31/2017
12/31/2016
12/31/2015
12/31/2014
12/31/2013
12/31/2012
Revenues96,43033,86418,01627,30915,2167,813 
Revenue, net33,86418,01622,44815,2167,813 
Cost of revenue
(Cost of Goods and Services Sold)
(41,057)      
Gross profit:55,37333,86418,01627,30915,2167,813 
Operating expenses(254,866)(112,800)(135,224)(116,224)(74,616)(50,733)(22,938)
Other undisclosed operating income41,057      
Operating loss:(158,436)(78,936)(117,208)(88,915)(59,400)(42,920)(22,938)
Nonoperating income (expense)1,24420,020(753)(2,198)(2,115)(2,097)(1,182)
Other nonoperating income (expense)1,24420,020(753)(2,198)(2,249)(2,115)(1,289)
Interest and debt expense(45,774)(4,215)(1,228)(153)(2,384)(2,132)(1,397)
Loss from continuing operations before equity method investments, income taxes:(202,966)(63,131)(119,189)(91,265)(63,899)(47,149)(25,516)
Other undisclosed income from continuing operations before income taxes      1,289
Net loss:(202,966)(63,131)(119,189)(91,265)(63,899)(47,149)(24,227)
Other undisclosed net income attributable to parent45,7744,2151,2281532,2492,115 
Net loss attributable to parent:(157,192)(58,916)(117,961)(91,113)(61,649)(45,035)(24,227)
Other undisclosed net loss available to common stockholders, basic (19,259)    (314)
Net loss available to common stockholders, diluted:(157,192)(78,175)(117,961)(91,113)(61,649)(45,035)(24,540)

Comprehensive Income ($ in thousands)

12/31/2018
12/31/2017
12/31/2016
12/31/2015
12/31/2014
12/31/2013
12/31/2012
Net loss:(202,966)(63,131)(119,189)(91,265)(63,899)(47,149)(24,227)
Comprehensive loss, net of tax, attributable to parent:(202,966)(63,131)(119,189)(91,265)(63,899)(47,149)(24,227)

Statements sources

The financial statements are based on the company's filings with the The U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.

Login to ReadyRatios

 

Have you forgotten your password?

Are you a new user?

Login As
You can log in if you are registered at one of these services: